An expression system to screen for inhibitors of parasite glucose transporters

Molecular and Biochemical Parasitology

Volumn 162, Issue 1, 2008, Pages 71-76

  Feistel, Torben ^a   Hodson, Cheryl A ^b   Peyton, David H ^b   Landfear, Scott M ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND STATE UNIVERSITY   (United States)

Author keywords

Glucose transporter; High throughput screening; Leishmania mexicana; Null mutant; Plasmodium falciparum

Indexed keywords

3 O UNDEC 10 ENYL DEXTRO GLUCOSE; GLUCOSE DERIVATIVE; GLUCOSE TRANSPORTER; UNCLASSIFIED DRUG;

ARTICLE; ASSAY; CONTROLLED STUDY; CULTURE MEDIUM; GLUCOSE TRANSPORT; GROWTH INHIBITION; LEISHMANIA MEXICANA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMASTIGOTE; SCREENING;

ANIMALS; ANTIMALARIALS; CULTURE MEDIA; GLUCOSE; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HUMANS; LEISHMANIA MEXICANA; MUTATION; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS;

LEISHMANIA MEXICANA; PLASMODIUM FALCIPARUM; PROTOZOA; TRYPANOSOMA BRUCEI;

EID: 52049098896     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbiopara.2008.07.005     Document Type: Article

References (28)

1. Croft S.L., Sundar S., and Fairlamb A.H. Drug resistance in leishmaniasis. Clin Microbiol Rev 19 1 (2006) 111-126
2. Daily J.P. Antimalarial drug therapy: the role of parasite biology and drug resistance. J Clin Pharmacol 46 12 (2006) 1487-1497
3. Matovu E., Seebeck T., Enyaru J.C., and Kaminsky R. Drug resistance in Trypanosoma brucei spp., the causative agents of sleeping sickness in man and nagana in cattle. Microbes Infect 3 9 (2001) 763-770
4. Leite E.A., Grabe-Guimaraes A., Guimaraes H.N., Machado-Coelho G.L., Barratt G., and Mosqueira V.C. Cardiotoxicity reduction induced by halofantrine entrapped in nanocapsule devices. Life Sci 80 14 (2007) 1327-1334
5. Burchmore R.J., Rodriguez-Contreras D., McBride K., et al. Genetic characterization of glucose transporter function in Leishmania mexicana. Proc Natl Acad Sci USA 100 7 (2003) 3901-3906
6. Rodriguez-Contreras D., Feng X., Keeney K.M., Bouwer H.G., and Landfear S.M. Phenotypic characterization of a glucose transporter null mutant in Leishmania mexicana. Mol Biochem Parasitol (2007)
7. Barrett M.P., Tetaud E., Seyfang A., Bringaud F., and Baltz T. Functional expression and characterization of the Trypanosoma brucei procyclic glucose transporter, THT2. Biochem J 312 Pt 3 (1995) 687-691
8. Cazzulo J.J. Aerobic fermentation of glucose by trypanosomatids. FASEB J 6 13 (1992) 3153-3161
9. Verlinde C.L., Hannaert V., Blonski C., et al. Glycolysis as a target for the design of new anti-trypanosome drugs. Drug Resist Update 4 1 (2001) 50-65
10. Bringaud F., and Baltz T. Differential regulation of two distinct families of glucose transporter genes in Trypanosoma brucei. Mol Cell Biol 13 2 (1993) 1146-1154
11. Joet T., Eckstein-Ludwig U., Morin C., and Krishna S. Validation of the hexose transporter of Plasmodium falciparum as a novel drug target. Proc Natl Acad Sci USA 100 13 (2003) 7476-7479
12. Azema L., Claustre S., Alric I., et al. Interaction of substituted hexose analogues with the Trypanosoma brucei hexose transporter. Biochem Pharmacol 67 3 (2004) 459-467
13. Mueckler M., Caruso C., Baldwin S.A., et al. Sequence and structure of a human glucose transporter. Science 229 4717 (1985) 941-945
14. Kirk K., and Saliba K.J. Targeting nutrient uptake mechanisms in Plasmodium. Curr Drug Targets 8 1 (2007) 75-88
15. Manolescu A.R., Witkowska K., Kinnaird A., Cessford T., and Cheeseman C. Facilitated hexose transporters: new perspectives on form and function. Physiology (Bethesda) 22 (2007) 234-240
16. LeBowitz J.H., Coburn C.M., and Beverley S.M. Simultaneous transient expression assays of the trypanosomatid parasite Leishmania using beta-galactosidase and beta-glucuronidase as reporter enzymes. Gene 103 1 (1991) 119-123
17. Seyfang A., and Landfear S.M. Four conserved cytoplasmic sequence motifs are important for transport function of the Leishmania inositol/H(+) symporter. J Biol Chem 275 8 (2000) 5687-5693
18. Iovannisci D.M., and Ullman B. High efficiency plating method for Leishmania promastigotes in semidefined or completely-defined medium. J Parasitol 69 4 (1983) 633-636
19. Ikekawa T., Irinoda K., Saze K., et al. Studies on synthesis of 3-O-alkyl-d-glucose and 3-O-alkyl-d-allose derivatives and their biological activities. Chem Pharm Bull (Tokyo) 35 7 (1987) 2894-2899
20. Ter Kuile B.H., and Opperdoes F.R. A chemostat study on proline uptake and metabolism of Leishmania donovani. J Protozool 39 5 (1992) 555-558
21. Woodrow C.J., Penny J.I., and Krishna S. Intraerythrocytic Plasmodium falciparum expresses a high affinity facilitative hexose transporter. J Biol Chem 274 11 (1999) 7272-7277
22. Mueckler M., Hresko R.C., and Sato M. Structure, function and biosynthesis of GLUT1. Biochem Soc Trans 25 3 (1997) 951-954
23. 50) of an enzymatic reaction. Biochem Pharmacol 22 23 (1973) 3099-3108
24. Joet T., Holterman L., Stedman T.T., et al. Comparative characterization of hexose transporters of Plasmodium knowlesi, Plasmodium yoelii and Toxoplasma gondii highlights functional differences within the apicomplexan family. Biochem J 368 Pt 3 (2002) 923-929
25. Mikus J., and Steverding D. A simple colorimetric method to screen drug cytotoxicity against Leishmania using the dye Alamar Blue. Parasitol Int 48 3 (2000) 265-269
26. Ionita M., Krishna S., Leo P.M., Morin C., and Patel A.P. Interaction of O-(undec-10-en)-yl-d-glucose derivatives with the Plasmodium falciparum hexose transporter (PfHT). Bioorg Med Chem Lett (2007)
27. Martin R.E., Henry R.I., Abbey J.L., Clements J.D., and Kirk K. The 'permeome' of the malaria parasite: an overview of the membrane transport proteins of Plasmodium falciparum. Genome Biol 6 3 (2005) R26
28. Wieczorke R., Krampe S., Weierstall T., Freidel K., Hollenberg C.P., and Boles E. Concurrent knock-out of at least 20 transporter genes is required to block uptake of hexoses in Saccharomyces cerevisiae. FEBS Lett 464 3 (1999) 123-128